Stocksigma LogoStocksigma Logo

Accretion Nutraveda Reports Robust H1 FY27 Performance with Revenue Doubling YoY

Accretion Nutraveda Limited reported robust financial results for H1 FY27, with total income from operations surging 109.35% YoY to ₹29.44 crore

Accretion Nutraveda Reports Robust H1 FY27 Performance with Revenue Doubling YoY

Accretion Nutraveda Ltd · Investor Presentation · 03 Nov 2026, 11:29 pm

Accretion Nutraveda Reports Robust H1 FY27 Performance with Revenue Doubling YoY Accretion Nutraveda Limited reported robust financial results for H1 FY27, with total income from operations surging 109.35% YoY to ₹29.44 crore. EBITDA rose 88.03% YoY to ₹6.26 crore with a 21.27% margin, while PAT increased 98.66% YoY to ₹4.73 crore (16.06% margin), translating to an EPS of ₹6.53. Net worth expanded to ₹40.2 crore as of 30th Sep'26. Growth was driven by broad-based demand across Ayurvedic and nutraceutical segments, supported by CDMO services, brand exports, and ongoing capacity and automation expansions.

Original exchange filing (PDF)

More announcements from Accretion Nutraveda Ltd

All Accretion Nutraveda Ltd announcements